$135 Million is the total value of Ally Bridge Group (NY) LLC's 21 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 36.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LNTH | Sell | LANTHEUS HLDGS INC | $15,763,000 | +65.3% | 285,000 | -13.6% | 11.68% | +250.7% |
| ISEE | Buy | IVERIC BIO INC | $10,940,000 | +19.0% | 650,000 | +18.2% | 8.11% | +152.3% |
| GH | Buy | GUARDANT HEALTH INC | $10,598,000 | +0.9% | 160,000 | +52.4% | 7.86% | +114.0% |
| ARVN | Sell | ARVINAS INC | $10,095,000 | -46.6% | 150,000 | -34.8% | 7.48% | +13.3% |
| COGT | Sell | COGENT BIOSCIENCES INC | $9,808,000 | -23.9% | 1,309,430 | -12.8% | 7.27% | +61.4% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $9,171,000 | -23.3% | 496,012 | -18.0% | 6.80% | +62.7% |
| FATE | Sell | FATE THERAPEUTICS INC | $7,037,000 | -55.5% | 181,500 | -32.8% | 5.22% | -5.5% |
| NUVB | Sell | NUVATION BIO INC | $5,981,000 | -41.2% | 1,137,152 | -5.0% | 4.43% | +24.6% |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $5,952,000 | – | 170,000 | +100.0% | 4.41% | – |
| Sell | SOMALOGIC INC | $5,895,000 | -36.7% | 735,000 | -8.1% | 4.37% | +34.3% | |
| Sell | ISOPLEXIS CORP | $5,660,000 | -65.2% | 1,650,118 | -6.8% | 4.20% | -26.2% | |
| Buy | RAPID MICRO BIOSYSTEMS INC | $4,751,000 | +2.0% | 699,664 | +59.8% | 3.52% | +116.2% | |
| NAUT | Sell | NAUTILUS BIOTECHNOLOGY INC | $4,690,000 | -26.1% | 1,080,566 | -11.8% | 3.48% | +56.7% |
| NTLA | Sell | INTELLIA THERAPEUTICS INC | $4,360,000 | -43.3% | 60,000 | -7.7% | 3.23% | +20.3% |
| SYRS | Sell | SYROS PHARMACEUTICALS INC | $4,004,000 | -65.3% | 3,364,895 | -4.9% | 2.97% | -26.4% |
| GOSS | Sell | GOSSAMER BIO INC | $3,906,000 | -27.3% | 450,000 | -5.3% | 2.90% | +54.2% |
| JNCE | Sell | JOUNCE THERAPEUTICS INC | $3,735,000 | -22.2% | 550,000 | -4.3% | 2.77% | +65.0% |
| STOK | Sell | STOKE THERAPEUTICS INC | $3,684,000 | -17.0% | 175,000 | -5.4% | 2.73% | +76.1% |
| Sell | SIGHT SCIENCES INC | $3,639,000 | -39.5% | 314,804 | -8.0% | 2.70% | +28.3% | |
| MDVL | MEDAVAIL HOLDINGS INC | $2,836,000 | -30.6% | 2,920,780 | 0.0% | 2.10% | +47.1% | |
| VERV | Sell | VERVE THERAPEUTICS INC | $2,404,000 | -40.9% | 105,360 | -4.5% | 1.78% | +25.3% |
| MGNX | Exit | MACROGENICS INC | $0 | – | -30,000 | -100.0% | -0.17% | – |
| CYT | Exit | CYTEIR THERAPEUTICS INC | $0 | – | -319,538 | -100.0% | -1.27% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -1,815,000 | -100.0% | -2.06% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -406,986 | -100.0% | -2.72% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -185,000 | -100.0% | -2.73% | – |
| IDYA | Exit | IDEAYA BIOSCIENCES INC | $0 | – | -430,000 | -100.0% | -3.55% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -120,000 | -100.0% | -3.78% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -85,000 | -100.0% | -4.36% | – |
| RGEN | Exit | REPLIGEN CORP | $0 | – | -70,000 | -100.0% | -6.48% | – |
| NTRA | Exit | NATERA INC | $0 | – | -268,000 | -100.0% | -8.75% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Fan Yu #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDAVAIL HOLDINGS INC | 11 | Q2 2023 | 8.9% |
| UNUM THERAPEUTICS INC | 8 | Q3 2022 | 7.3% |
| RAPID MICRO BIOSYSTEMS INC-A | 8 | Q2 2023 | 3.5% |
| FATE THERAPEUTICS INC | 7 | Q2 2022 | 5.8% |
| VIRIDIAN THERAPEUTICS INC | 7 | Q2 2023 | 6.8% |
| SYROS PHARMACEUTICALS INC | 7 | Q2 2022 | 4.9% |
| REPLIGEN CORP | 7 | Q4 2022 | 6.5% |
| NAUTILUS BIOTECHNOLOGY INC | 7 | Q4 2022 | 3.8% |
| ARVINAS INC | 6 | Q1 2022 | 7.5% |
| NUVATION BIO INC | 6 | Q2 2022 | 4.9% |
View Ally Bridge Group (NY) LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | November 19, 2020 | 1,420,500 | 8.0% |
View Ally Bridge Group (NY) LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-06-21 |
| 13F-HR | 2023-05-15 |
| 4 | 2023-03-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Ally Bridge Group (NY) LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.